Pharma Aids has been growing earnings at an average annual rate of 10%, while the Packaging industry saw earnings growing at 5.6% annually. Revenues have been growing at an average rate of 11.7% per year. Pharma Aids's return on equity is 15.5%, and it has net margins of 15.3%.
Key information
9.99%
Earnings growth rate
9.99%
EPS growth rate
Packaging Industry Growth
2.63%
Revenue growth rate
11.66%
Return on equity
15.53%
Net Margin
15.27%
Last Earnings Update
31 Dec 2025
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Pharma Aids makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
DSE:PHARMAID Revenue, expenses and earnings (BDT Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Dec 25
474
72
49
0
30 Sep 25
453
67
48
0
30 Jun 25
438
64
47
0
31 Mar 25
417
53
46
0
31 Dec 24
432
62
44
0
30 Sep 24
431
67
44
0
30 Jun 24
421
61
44
0
31 Mar 24
409
51
44
0
31 Dec 23
376
24
42
0
30 Sep 23
329
-1
38
0
30 Jun 23
308
-6
37
0
31 Mar 23
302
-13
46
0
31 Dec 22
303
5
46
0
30 Sep 22
310
25
46
0
30 Jun 22
323
35
47
0
31 Mar 22
325
60
40
0
31 Dec 21
315
58
39
0
30 Sep 21
301
54
39
0
30 Jun 21
280
50
38
0
31 Mar 21
272
46
37
0
31 Dec 20
255
47
35
0
30 Sep 20
262
51
34
0
30 Jun 20
270
52
34
0
31 Mar 20
259
51
32
0
31 Dec 19
265
50
32
0
30 Sep 19
255
48
32
0
30 Jun 19
249
48
30
0
31 Mar 19
252
50
26
0
31 Dec 18
246
51
26
0
30 Sep 18
248
50
27
0
30 Jun 18
235
47
26
0
31 Mar 18
227
46
24
0
31 Dec 17
212
39
24
0
30 Sep 17
193
35
22
0
30 Jun 17
180
30
21
0
31 Mar 17
176
28
20
0
31 Dec 16
166
26
19
0
30 Sep 16
161
25
18
0
30 Jun 16
152
23
17
0
31 Mar 16
139
23
17
0
31 Dec 15
137
22
16
0
30 Sep 15
138
23
16
0
30 Jun 15
147
25
15
0
Quality Earnings: PHARMAID has high quality earnings.
Growing Profit Margin: PHARMAID's current net profit margins (15.3%) are higher than last year (14.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: PHARMAID's earnings have grown by 10% per year over the past 5 years.
Accelerating Growth: PHARMAID's earnings growth over the past year (16%) exceeds its 5-year average (10% per year).
Earnings vs Industry: PHARMAID earnings growth over the past year (16%) exceeded the Packaging industry 4.1%.
Return on Equity
High ROE: PHARMAID's Return on Equity (15.5%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/05/07 10:17
End of Day Share Price
2026/05/07 00:00
Earnings
2025/12/31
Annual Earnings
2025/06/30
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Pharma Aids Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.